Related Experiment Videos
Suppressor cell induction by the anticancer drug spirogermanium.
International Journal of Immunopharmacology
|January 1, 1987
Summary
Spirogermanium, a compound with known antitumor properties, was found to suppress immune responses in mice. It inhibited antibody synthesis and activated suppressor cells, primarily of B cell lineage, impacting adaptive immunity.
Area of Science:
- Immunology
- Pharmacology
- Medicinal Chemistry
Background:
- Spirogermanium is a metal-containing compound with reported antitumor, antiarthritic, antimalarial, and immunoregulatory activities.
- Its precise immunomodulatory mechanisms, particularly in vivo, require further elucidation.
Purpose of the Study:
- To investigate the immunoregulatory effects of spirogermanium in a murine model.
- To characterize the immune cells responsible for spirogermanium-induced suppression of antibody synthesis.
Main Methods:
- Administration of spirogermanium to BDF1 mice, followed by assessment of antibody synthesis to sheep red blood cells (SRBC) in vivo.
- In vitro analysis of spleen cells from treated mice, including co-culture assays with normal cells and mitogens (Concanavalin A).
- Cell characterization using techniques such as anti-Thy-1.2 antiserum treatment, radiation resistance assays, nylon wool adherence, plastic adherence, Sephadex G10 chromatography, and flow cytometry with fluorescent antibodies.
Main Results:
- Spirogermanium significantly inhibited in vivo antibody synthesis to SRBC in BDF1 mice.
- Spleen cells from spirogermanium-treated mice suppressed both antibody responses to SRBC and mitogenic responses to Concanavalin A in normal cells.
- The suppressor cells were identified as non-T cells, exhibiting radiation resistance, nylon wool adherence, and partial plastic adherence, suggesting a macrophage component.
- Further analysis revealed a plastic non-adherent suppressor cell population that was immunoglobulin-positive (90%), indicating a B cell lineage.
Conclusions:
- Spirogermanium exerts potent immunosuppressive effects in vivo, primarily through the induction of suppressor cells.
- These suppressor cells appear to be heterogeneous, involving both macrophage-like and B cell-like populations.
- The findings suggest that spirogermanium's immunoregulatory activity may be linked to its ability to modulate B cell and possibly macrophage function.